These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

533 related items for PubMed ID: 14562136

  • 1. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model.
    De Young L, Yu D, Freeman D, Brock GB.
    Int J Impot Res; 2003 Oct; 15(5):347-54. PubMed ID: 14562136
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Endothelial rehabilitation: the impact of chronic PDE5 inhibitors on erectile function and protein alterations in cavernous tissue of diabetic rats.
    De Young LX, Domes T, Lim K, Carson J, Brock GB.
    Eur Urol; 2008 Jul; 54(1):213-20. PubMed ID: 18342431
    [Abstract] [Full Text] [Related]

  • 5. Effect of combination endothelial nitric oxide synthase gene therapy and sildenafil on erectile function in diabetic rats.
    Bivalacqua TJ, Usta MF, Champion HC, Leungwattanakij S, Dabisch PA, McNamara DB, Kadowitz PJ, Hellstrom WJ.
    Int J Impot Res; 2004 Feb; 16(1):21-9. PubMed ID: 14963467
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Long-term continuous treatment with sildenafil ameliorates aging-related erectile dysfunction and the underlying corporal fibrosis in the rat.
    Ferrini MG, Kovanecz I, Sanchez S, Vernet D, Davila HH, Rajfer J, Gonzalez-Cadavid NF.
    Biol Reprod; 2007 May; 76(5):915-23. PubMed ID: 17287493
    [Abstract] [Full Text] [Related]

  • 9. Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes.
    Zhang XH, Filippi S, Morelli A, Vignozzi L, Luconi M, Donati S, Forti G, Maggi M.
    J Sex Med; 2006 Mar; 3(2):253-64; discussion 264-5, author reply 265-6. PubMed ID: 16490018
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology and drug interaction effects of the phosphodiesterase 5 inhibitors: focus on alpha-blocker interactions.
    Kloner RA.
    Am J Cardiol; 2005 Dec 26; 96(12B):42M-46M. PubMed ID: 16387566
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic strategies for optimizing PDE-5 inhibitor therapy in patients with erectile dysfunction considered difficult or challenging to treat.
    de Tejada IS.
    Int J Impot Res; 2004 Jun 26; 16 Suppl 1():S40-2. PubMed ID: 15224136
    [Abstract] [Full Text] [Related]

  • 12. Resveratrol and sildenafil synergistically improve diabetes-associated erectile dysfunction in streptozotocin-induced diabetic rats.
    Bai Y, An R.
    Life Sci; 2015 Aug 15; 135():43-8. PubMed ID: 26006044
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of action of PDE5 inhibition in erectile dysfunction.
    Corbin JD.
    Int J Impot Res; 2004 Jun 15; 16 Suppl 1():S4-7. PubMed ID: 15224127
    [Abstract] [Full Text] [Related]

  • 14. In vivo and in vitro response of corpus cavernosum to phosphodiesterase-5 inhibition in the hypercholesterolaemic rabbit.
    Firoozi F, Longhurst PA, White MD.
    BJU Int; 2005 Jul 15; 96(1):164-8. PubMed ID: 15963142
    [Abstract] [Full Text] [Related]

  • 15. Enhancement of both EDHF and NO/cGMP pathways is necessary to reverse erectile dysfunction in diabetic rats.
    Angulo J, Cuevas P, Gabancho S, Gonzalez-Corrochano R, Videla S, Saenz de Tejada I.
    J Sex Med; 2005 May 15; 2(3):341-6. PubMed ID: 16422865
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Optimization of purine based PDE1/PDE5 inhibitors to a potent and selective PDE5 inhibitor for the treatment of male ED.
    Boyle CD, Xu R, Asberom T, Chackalamannil S, Clader JW, Greenlee WJ, Guzik H, Hu Y, Hu Z, Lankin CM, Pissarnitski DA, Stamford AW, Wang Y, Skell J, Kurowski S, Vemulapalli S, Palamanda J, Chintala M, Wu P, Myers J, Wang P.
    Bioorg Med Chem Lett; 2005 May 02; 15(9):2365-9. PubMed ID: 15837326
    [Abstract] [Full Text] [Related]

  • 18. NCX-911, a novel nitric oxide-releasing PDE5 inhibitor relaxes rabbit corpus cavernosum in the absence of endogenous nitric oxide.
    Kalsi JS, Kell PD, Cellek S, Ralph DJ.
    Int J Impot Res; 2004 Apr 02; 16(2):195-200. PubMed ID: 14961060
    [Abstract] [Full Text] [Related]

  • 19. Effect of sildenafil on cyclic nucleotide phosphodiesterase activity, vascular tone and calcium signaling in rat pulmonary artery.
    Pauvert O, Lugnier C, Keravis T, Marthan R, Rousseau E, Savineau JP.
    Br J Pharmacol; 2003 Jun 02; 139(3):513-22. PubMed ID: 12788811
    [Abstract] [Full Text] [Related]

  • 20. Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells.
    Wharton J, Strange JW, Møller GM, Growcott EJ, Ren X, Franklyn AP, Phillips SC, Wilkins MR.
    Am J Respir Crit Care Med; 2005 Jul 01; 172(1):105-13. PubMed ID: 15817798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.